Come up with a name for your new list and we'll add to it:
ImaRx Therapeutics raised a round of funding on November 12, 2003. Investors include
Edson Moore Healthcare Ventures.
We are a biopharmaceutical company developing and commercializing therapies for vascular disorders. Our research and development efforts are focused on therapies for stroke and other vascular disorder…